HCA Healthcare, Inc. (NYSE:HCA) Announces Quarterly Dividend of $0.78

HCA Healthcare, Inc. (NYSE:HCA) announced a quarterly dividend on Friday, April 24th. Stockholders of record on Tuesday, June 16th will be given a dividend of 0.78 per share on Tuesday, June 30th. This represents a c) dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 16th.

HCA Healthcare has increased its dividend payment by an average of 0.3%per year over the last three years and has increased its dividend every year for the last 6 years. HCA Healthcare has a payout ratio of 11.1% meaning its dividend is sufficiently covered by earnings. Analysts expect HCA Healthcare to earn $33.19 per share next year, which means the company should continue to be able to cover its $3.12 annual dividend with an expected future payout ratio of 9.4%.

HCA Healthcare Stock Performance

Shares of HCA opened at $433.04 on Friday. HCA Healthcare has a 52-week low of $321.39 and a 52-week high of $556.52. The firm has a market cap of $96.81 billion, a price-to-earnings ratio of 15.26, a PEG ratio of 1.59 and a beta of 1.36. The business’s fifty day moving average is $505.45 and its 200-day moving average is $485.06.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the company earned $6.45 earnings per share. HCA Healthcare’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts forecast that HCA Healthcare will post 30.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Royal Bank Of Canada upped their target price on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a report on Friday, March 27th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a report on Friday. UBS Group upped their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Finally, Oppenheimer upped their price target on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $534.41.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.